Found: 22
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2025 · pp. 10–20
Dyakova M.E., Vinogradova T.I., Ariel B.M., Esmedlyayeva D.S., Panteleev A.M., Blum N.M., Mukhametshina E.R., Dogonadze M.Z., Kurdoyak A.C., Zabolotnykh N.V., Lavrova A.I., Vishnevskiy A.A., Yablonskiy P.K.
Introduction. The determination of inflammatory markers used to monitor the course of the disease and monitor the effectiveness of treatment. Goal. To evaluate biochemical markers of inflammation in cerebrospinal fluid (CSF) and blood serum in experimental men…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2025 · pp. 77–85
Kudryashov G.G., Vinogradova T.I., Zmitrichenko Yu.G., Krylova Yu.S., Dogonadze M.Z., Zabolotnyh N.V., Dyakova M.E., Esmedlyaeva D.S., Tochilnikov G.V., Nefedov A.O., Agafonov G.M., Yablonskiy P.K.
Aim of the study. The possibility of using antitumor drugs against the background of active tuberculosis is an unresolved problem of modern medicine. The aim of the experimental study was to study the course of tuberculosis infection against the background of …
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2025 · pp. 34–40
Kudriashov G.G., Krylova Yu.S., Zmitrichenko Yu.G., Tochilnikov G.V., Afafonov G.M., Vinogradova T.I., Yablonskii P.K.
Introduction. Up to 20% of tuberculosis patients suffer from malignant neoplasms. In this case, the combination of both diseases in the lung is a particular problem. More than 60% of patients cannot complete combination therapy due to drug-resistant MBT. The a…
ОБЗОР2024 · pp. 14–20
Zinchenko Y.S., Muraviov A.N., Kudryashov G.G., Kornilova A.I., Dyatlova A.S., Polyakova V.O.
Introduction. Sarcoidosis is a systemic granulomatous disease of unknown origin. The study of its features and the development of new diagnostic and treatment methods are limited by the absence of generally accepted experimental models. The purpose of the revi…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 21–28
Krylova Yu.S., Kudriashov G.G., Tochilnikov G.V., Vinogradova T.I., Dokhov M.A., Yablonskii P.K.
Introduction. Lung cancer occupies a leading position in the structure of mortality from cancer. Chronic inflammation characteristic of tuberculosis increases the risk of lung cancer. Currently, more and more information is emerging confirming the cause-and-ef…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 35–42
Kudriashov G.G., Zmitrichenko Yu.G., Vinogradova T.I., Dogonadze M.Z., Zabolotnyh N.V., Dyakova M.E., Esmedlyaeva D.S., Tochilnikov G.V., Nefedov A.O., Krylova Yu.S., Yablonskii P.K.
Introduction. Treatment of the coexistent pathology of lung cancer and tuberculosis remains the prerogative of experimental research, since the optimal treatment strategy for the coexistence of these two diseases has not yet been developed. The purpose was to …
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2023 · pp. 41–46
Leontyeva D.O., Mironova E.S., Krylova Yu.S., Kvetnoy I.M., Yablonsky P.K., Drobintseva A.O.
Introduction. Tuberculosis is a socially significant disease, which is based on chronic granulomatous inflammation with the formation of fibrosis. The signaling molecules CD44 and ICAM-1 play an important role in the process of migration of immune cells from t…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2023 · pp. 27–35
Vinogradova T.I., Esmedlyayeva D.S., Dyakova M.E., Muravyev A.N., Remezova A.N., Ariel B.M., Bogdanova E.O., Dogonadze M.Z., Zabolotnykh N.V., Yudintseva N.Yu., Polyakova V.O., Yablonskiy P.K.
Introduction. The use of mesenchymal stem cells (MSCs) is recognized as a promising direction for the treatment of diseases with a predominance of inflammation and sclerosis in the pathogenesis, which includes nephrotuberculosis (NT). Target. Studying the effe…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2023 · pp. 51–57
Esmedlyaeva D.S., Alekseeva N.P., Dyakova M.E.
Introduction. The search for molecular markers of adverse treatment outcomes in individuals with pulmonary tuberculosis (PT) is relevant due to the worldwide increase in drug resistance of Mycobacterium tuberculosis (MBT) strains to anti-tuberculosis drugs (PT…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2023 · pp. 25–32
Kudriashov G.G., Vinogradova T.I., Zmitrichenko Yu.G., Dogonadze M.Z., Zabolotnyh N.V., Dyakova M.E., Esmedlyaeva D.S., Gavrilov P.V., Azarov A.A., Tochilnikov G.V., Nefedov A.O., Krylova Yu.S., Yablonskii P.K.
Introduction. Lung cancer and tuberculosis, make a significant affect to the morbidity and mortality of the population in Russia and in the world. Strategy of medication therapy has not been developed for cases when these diseases are combined. The aim of the …
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2023 · pp. 43–49
Kudriashov G.G., Nefedov A.O., Tochilnikov G.V., Zmitrichenko Yu.G., Krylova Yu.S., Dogonadze M.Z., Gavrilov P.V., Azarov A.A., Davydenkova E.A., Vinogradova T.I., Yablonskii P.K.
Introduction. One of the problems of modern medicine is the low efficiency of treatment of patients with a coexistence of lung cancer and active tuberculosis. Optimal treatment regimens for coexistence pathology have not been developed at present. In recent ye…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2022 · pp. 50–55
Zorkaltseva E.Yu., Egorova Yu.O., Plotnikova Yu.K., Bazhenova Yu.V.
Introduction. The epidemiological process in tuberculosis is negatively affected by the HIV epidemic, the identification of vulnerable groups in relation to the unfavorable course of tuberculosis in combination with HIV infection will improve approaches to tre…
ОБЗОР2022 · pp. 12–15
Krylova Yu.S., Kudriashov G.G., Nefedov A.O., Dokhov M.A., Zakharchenko A.O., Yablonskii P.K.
The review is devoted to the analysis of modern ideas about the molecular mechanisms of tumor transformation in tuberculosis; signal molecules are described, which may be biomarkers and targets for optimizing personalized diagnosis and targeted therapy of the …
ОБЗОР2022 · pp. 18–27
Tuberculosis remains one of the leading causes of death from infectious diseases in the world. According to WHO data, tuberculosis is diagnosed annually in more than 100 million people and causes 4.5 thousand deaths. Despite a steady decline in the main epidem…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2020
Yablonsky P.K., Polyakova V.O., Krylova Yu.S., Drobintseva A.O., Leonteva D.O., Sokolovich E.G., Kvetnoy I.M.
Introduction. Sarcoidosis is a systemic granulomatous disease of unknown etiology, which leads to disruption of the human respiratory system and can lead to damage to other systems. In clinical practice, doctors often run into difficulties in differentiating s…
ОБЗОР2020
Borodulina E.A., Yakovleva E.V.
Iron is an essential trace element not only for the human body, but also for some microorganisms, including mycobacterium tuberculosis. Being strict aerobes, mycobacteria receive iron from the human body using the siderophore transporter system. Iron deficienc…
ОБЗОР2018
Snalina N.E., Sychev D.A.
Currently, tuberculosis is the second leading cause of death from an infectious agent in the world and an important social and medical-biological problem. The first-line drug isoniazid is one of the most effective antituberculosisdrug, however it has a wide sp…
ОБЗОР2017
Gurova Ya.V., Mordyk A.V.
In the context of the continuing importance of the problem of tuberculosis there must be the selection both of priority areas to combat it, and priority category of patients. The most common form of TB among new cases is infiltrative and successful treatment o…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2016
Sin’kov V.V., Ogarkov O.B., Mokrousov I.V., Zhdanova S.N.
Introduction. Russian population of Mycobacterium tuberculosis includes both highly virulent and less virulent strains; the Ural genotype makes an example of the latters. The aim of study was investigation of the most significant synonymous and non-synonymous …
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2015
Ludannyy R.I., Alvarez Figueroa M.V., Prokopenko A.V., Valdokhina A.V., Shipulin G.A.
Introduction. The phenomenon of drug resistance of Mycobacterium tuberculosis complex is extremely complicated. The determination of the genetic changes is not always able to explain reasons of this effect clearly. The aim of the study. Molecular genetic analy…